Rinvoq Warning Label Updated to Add Cancer and Heart Risks Seen With Xeljanz Side Effects
Rinvoq will now carry label warnings on cancer and heart risks which were first discovered through a study of Xeljanz side effects.
Tag Archives: Ulcerative Colitis
-
-
Eli Lilly-Funded Study Claims Side Effects of Olumiant Do Not Warrant Same Adverse Label Warnings as Xeljanz
A new study announced by Eli Lilly appears to suggest Olumiant, a rheumatoid arthritis drug, does not need the same label warnings for heart problems as Xeljanz, it's competitor.
-
Xeljanz FDA Label Warning Update Adds Information About Risk of Cancer, Blood Clots and Heart Side Effects
The FDA is requiring new label warnings for Xeljanz and similar drugs, following a review which revealed links between increased risks of heart attacks, strokes, blood clots, and lymphomas, as…
-
Ultra-Processed Food Consumption Could Increase Irritable Bowel Syndrome Risk: Study
A new study links the consumption of ultra-processed foods to an increased risk of IBD.
-
Side Effects of Stelara May Trigger Severe Cardiovascular Events: Study
A new study warns that Stelara can significantly increase the risk of heart problems and strokes among patients already at a high risk of coronary events.
-
Probiotics Do Little To Help With Gut Health: Report
Probiotics do little to help with gut health and are usually not worth the cost, according to guidelines in a new report.
-
FDA Approves High-Dose, Extended-Release Version of Xeljanz, Despite Blood Clot Risks
The FDA has approved higher dose formulations of extended release Xeljanz, despite concerns over the risk of potentially fatal blood clots.
-
Blood Clot Problems from Xeljanz Draw Updated EMA Warning for High Risk Patients
European regulators warn that Xeljanz should not be given to any patients at high risk of blood clots unless absolutely necessary.
-
Xeljanz Black Box Warning Added by FDA, Due to Risk of Blood Clots and Death
The FDA is warning that Pfizer's ulcerative colitis drug, Xeljanz, could cause pulmonary embolism and deep vein thrombosis at higher doses.
-
Xeljanz Side Effects at 10mg Dose Lead EMA To Place Restrictions on Use
European regulators have placed new restrictions on the use of Xeljanz while they continue to review potential pulmonary embolism risks.